Pilot grants to study the health of women and resources for women faculty at Yale gaining momentum
Even today, attention to research on women’s health remains far behind that of men, and fewer women faculty are pursuing opportunities to commercialize their research. Two organizations at Yale – Women’s Health Research at Yale (WHRY) and the Office of Cooperative Research (OCR) --- are looking to change those trends, offering grants and programs specifically aimed at supporting women’s health research and supporting women faculty who wish to seek funding to bring their discoveries to a commercial light.
Learning to lead: a new digital resource library for women faculty in medicine at Yale
The Women’s Leadership Resource Library launched online in April. The fully digital lending library, available to anyone with Yale Library access, includes books, podcasts, TED talks, online courses and other resources that address topics like building confidence, embracing vulnerability, knowing your worth, responding in crisis, and the soft skills needed to become an effective leader.
‘We need positive destruction’: Yale doctors discuss gender equity on Clubhouse
Inginia Genao, MD, kicked off a recent Clubhouse discussion on gender equity in medicine with a sobering statistic: research shows that nearly 40% of women become part time or leave medicine within six years of completing their residency. The discussion, held May 13, was hosted by the Yale Department of Internal Medicine.
WHRY and Elevate Expand Help for Women and Families in Need
Recognizing the urgent need to ensure the health of women in our communities, Women’s Health Research at Yale and Elevate, the university’s health policy lab, are collaborating to deploy interventions grounded in the latest and most reliable research directly to women and families.
Research Begun by WHRY Continues to Show Possible Pathway to Derail Dementia
Research is revealing the mechanisms that underlie the role of estradiol in memory so that next generation treatments for Alzheimer's disease and other dementias can specifically target these mechanisms and avoid the potential for negative side effects of systemic estrogen therapy.
Treatment with Genetically Altered Viruses Targets and Destroys Ovarian Cancer in Mice
Researchers have successfully eliminated chemotherapy-resistant ovarian cancer cells in mice using a single injection of two viruses genetically combined and altered to be safe, leading to long-term survival and demonstrating a potential breakthrough treatment for women.